Benign prostatic hyperplasia (BPH) is a common and progressive disease affecting aging men which has a significant impact on quality of life. The Optilume BPH Catheter System (Optilume BPH) is a prostatic dilation system that combines balloon dilation with a localized transfer of paclitaxel to maintain long term patency. Optilume BPH can be deployed using standard rigid cystoscopy without general anesthesia in an office setting. Prospective data indicate that Optilume BPH has favorable functional and sexual patient outcomes. Readers will familiarize themselves with Optilume BPH, significant historical studies and the technique for deploying Optilume BPH.
The Canadian journal of urology. 2023 Jun [Epub]
Dean S Elterman, Bruce Gao, Kevin C Zorn, Naeem Bhojani, Alexis Te, Bilal Chughtai, Steven A Kaplan
Division of Urology, Department of Surgery, University of Toronto, Ontario, Canada., Division of Urology, Centre hospitalier de l'Université de Montréal, Université de Montréal, Montreal, Quebec, Canada., Department of Urology, Weill Cornell Medical College-New York Presbyterian, New York, New York, USA., Icahn School of Medicine at Mount Sinai, New York, New York, USA.